Sponsored By:

5 Stocks With Strong Sales Growth — CRIS SWSH REGN APSA AGX

The best picks Portfolio Grader has to offer in this fundamental category

   

This week, these five stocks have the best ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.

Curis Inc. (NASDAQ: CRIS) is a drug discovery and development company that engages in the research and development of cancer therapeutics. For more information, get Portfolio Grader’s complete analysis of CRIS stock.

Swisher Hygiene (NASDAQ: SWSH) offers commercial hygiene services. For more information, get Portfolio Grader’s complete analysis of SWSH stock.

Regeneron Pharmaceuticals (NASDAQ: REGN) also gets A’s in Earnings Momentum, Analyst Earnings Revisions, Earnings Surprises, and Equity. Shares of the stock have risen 153.9% since January 1. This is better than the Nasdaq, which has seen an 11.5% increase over the same period. For more information, get Portfolio Grader’s complete analysis of REGN stock.

Alto Palermo (NASDAQ: APSA) is a real estate holding company that is primarily involved in acquiring, developing, and operating shopping center properties in Argentina. APSA also gets A’s in Earnings Growth, Equity, and Cash Flow. The current dividend yield is 2.4%. For more information, get Portfolio Grader’s complete analysis of APSA stock.

Argan (AMEX: AGX) plans, builds, manages and leases warehouses. AGX also gets A’s in Earnings Growth, Earnings Momentum, and Operating Margin Growth. For more information, get Portfolio Grader’s complete analysis of AGX stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, http://investorplace.com/2012/11/5-stocks-with-strong-sales-growth-cris-swsh-regn-apsa-agx-cris-swsh-regn/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.